4th Quarter - Report

ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY

Firm
Client
Income
—
Expenses
$90,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. HR 7008/HR 7667/HR 9297/HR 2617 S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S. 3791/HR 7051 - Access to Prescription Digital Therapeutics Act of 2022 - to create a benefit category in Medicare and Medicaid for prescription digital therapeutics HR 7213 - Equitable Community Access to Pharmacy Services Act of 2022 - to reimburse certain COVID-19 care services provided by pharmacists under Medicare Part B

LobbyistCovered position, as disclosed
TOM CASEY —
ADAM COLBORN —
JENNIFER LYNN MATHIEU —
EUGENIA LANSING TUNSTALL New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2617 (117th), H.R. 7008 (117th), H.R. 9297 (117th), S. 3791 (117th), H.R. 7213 (117th), S. 1362 (117th), H.R. 7051 (117th), H.R. 7667 (117th), S. 1909 (117th), H.R. 3554 (117th)

Medicare/Medicaid MMM

Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. HR 7008/HR 7667/HR 9297/HR 2617 S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S. 3791/HR 7051 - Access to Prescription Digital Therapeutics Act of 2022 - to create a benefit category in Medicare and Medicaid for prescription digital therapeutics HR 7213 - Equitable Community Access to Pharmacy Services Act of 2022 - to reimburse certain COVID-19 care services provided by pharmacists under Medicare Part B

LobbyistCovered position, as disclosed
TOM CASEY —
ADAM COLBORN —
JENNIFER LYNN MATHIEU —
EUGENIA LANSING TUNSTALL —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 3554 (117th), H.R. 7051 (117th), S. 1909 (117th), H.R. 9297 (117th), S. 3791 (117th), H.R. 7008 (117th), H.R. 7213 (117th), H.R. 2617 (117th), S. 1362 (117th), H.R. 7667 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.